HB 537Just filedInsurance & financial services
Requires health plans and Medicaid to cover GLP-1 drugs prescribed for obesity
Filed by
John BucyDDemocrat· House District 136· Filed Nov 9, 2026The short version · AI summary
Health benefit plans that cover prescription drugs would have to cover GLP-1 receptor agonist drugs used to treat obesity. The requirement reaches private insurers and HMOs, state employee, teacher and other public plans, and Medicaid, including managed care. It applies to plans delivered, issued or renewed on or after January 1, 2028. State agencies may delay parts of the Act while they seek any needed federal waiver. The bill sets no dollar limits or conditions on coverage.
What it means for you
If you have a plan with drug coverage, it would have to cover GLP-1 obesity drugs starting in 2028. The bill does not say what you would pay in copays or whether conditions apply.
One email when it moves, at most one a day. Unsubscribe in one click from any email.